Simcere Pharmaceutical Announces Financial Results for 2022 H1: 27% Year-Over-Year Revenue Growth, with Innovative Drugs Accounting for 65.4% of Total Revenue ...Middle East

PR Newswire - News
NANJING, China, Sept. 5, 2022 /PRNewswire/ -- Simcere Pharmaceutical Group Limited (2096.HK) announced its financial results for the first half of 2022. As of June 30, Simcere recorded operating revenue of RMB 2.7 billion for the first half of the year, with a year-over-year growth of...

Hence then, the article about simcere pharmaceutical announces financial results for 2022 h1 27 year over year revenue growth with innovative drugs accounting for 65 4 of total revenue was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Simcere Pharmaceutical Announces Financial Results for 2022 H1: 27% Year-Over-Year Revenue Growth, with Innovative Drugs Accounting for 65.4% of Total Revenue )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News